These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16753067)

  • 21. High thymidylate synthase expression is typical for sporadic MSI-H colorectal carcinoma.
    Okoń K; Klimkowska A; Wójcik P; Osuch C; Papla B; Stachura J
    Pol J Pathol; 2006; 57(1):29-33. PubMed ID: 16739880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal carcinomas with microsatellite instability display increased thymidylate synthase gene expression levels.
    Odin E; Wettergren Y; Nilsson S; Carlsson G; Gustavsson B
    Clin Colorectal Cancer; 2007 Nov; 6(10):720-7. PubMed ID: 18039426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.
    Russo A; Bazan V; Iacopetta B; Kerr D; Soussi T; Gebbia N;
    J Clin Oncol; 2005 Oct; 23(30):7518-28. PubMed ID: 16172461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High thymidylate synthase expression in colorectal cancer with microsatellite instability: implications for chemotherapeutic strategies.
    Ricciardiello L; Ceccarelli C; Angiolini G; Pariali M; Chieco P; Paterini P; Biasco G; Martinelli GN; Roda E; Bazzoli F
    Clin Cancer Res; 2005 Jun; 11(11):4234-40. PubMed ID: 15930362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P53 abnormalities and outcomes in colorectal cancer: a systematic review.
    Munro AJ; Lain S; Lane DP
    Br J Cancer; 2005 Feb; 92(3):434-44. PubMed ID: 15668707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of microsatellite instability and colorectal cancer prognosis.
    Popat S; Hubner R; Houlston RS
    J Clin Oncol; 2005 Jan; 23(3):609-18. PubMed ID: 15659508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma.
    Jones AM; Douglas EJ; Halford SE; Fiegler H; Gorman PA; Roylance RR; Carter NP; Tomlinson IP
    Oncogene; 2005 Jan; 24(1):118-29. PubMed ID: 15531920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
    Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
    Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis.
    Popat S; Matakidou A; Houlston RS
    J Clin Oncol; 2004 Feb; 22(3):529-36. PubMed ID: 14752076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.
    Longley DB; Latif T; Boyer J; Allen WL; Maxwell PJ; Johnston PG
    Semin Oncol; 2003 Jun; 30(3 Suppl 6):3-9. PubMed ID: 12802789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
    Arnold CN; Goel A; Boland CR
    Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
    Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
    J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma.
    Berglund A; Edler D; Molin D; Nordlinder H; Graf W; Glimelius B
    Anticancer Res; 2002; 22(6B):3653-9. PubMed ID: 12552972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study.
    Allegra CJ; Paik S; Colangelo LH; Parr AL; Kirsch I; Kim G; Klein P; Johnston PG; Wolmark N; Wieand HS
    J Clin Oncol; 2003 Jan; 21(2):241-50. PubMed ID: 12525515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.
    Etienne MC; Chazal M; Laurent-Puig P; Magné N; Rosty C; Formento JL; Francoual M; Formento P; Renée N; Chamorey E; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
    J Clin Oncol; 2002 Jun; 20(12):2832-43. PubMed ID: 12065560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer.
    Allegra CJ; Parr AL; Wold LE; Mahoney MR; Sargent DJ; Johnston P; Klein P; Behan K; O'Connell MJ; Levitt R; Kugler JW; Tria Tirona M; Goldberg RM
    J Clin Oncol; 2002 Apr; 20(7):1735-43. PubMed ID: 11919229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of p21/WAF1 expression by thymidylate synthase.
    Kastanos EK; Zajac-Kaye M; Dennis PA; Allegra CJ
    Biochem Biophys Res Commun; 2001 Jul; 285(2):195-200. PubMed ID: 11444825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC).
    Loukola A; Eklin K; Laiho P; Salovaara R; Kristo P; Järvinen H; Mecklin JP; Launonen V; Aaltonen LA
    Cancer Res; 2001 Jun; 61(11):4545-9. PubMed ID: 11389088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.